Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
Posted on: Thursday, 5 November 2009, 07:30 CST
LITTLE FALLS, N.J., Nov. 5 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Sidoti & Company, LLC Emerging Growth Research Institutional Investor Forum. The formal presentation is scheduled for 9:05 AM ET on Friday, November 20, 2009 at the Grand Hyatt New York, with a Q & A session immediately following the presentation. In addition, Mr. Krakauer and Seth R. Segel, Executive Vice President, will be available for separate one-on-one meetings during the day. The presentation will be available on the Investor Relations section of the Company's website: www.cantelmedical.com.
Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. For more information, please visit http://www.cantelmedical.com.
SOURCE Cantel Medical Corp.
Source: PR Newswire
Related Articles
- PolyOne Presented with Frost & Sullivan Medical Product Award
- Jonathan Salkin Named Executive Vice President of Devicor Medical Products
- Obagi Medical Products Presents In Vitro Data Showing Its Topical Vitamin C Serums Provide Greater Absorption and Stability Than a Leading Competitor
- Obagi Medical Products to Present at the Roth Capital Partners 19th Annual OC Conference
- Obagi Medical Products Presents Scientific Posters on Efficacy of CLENZIderm M.D. At the 65th Annual Meeting of the American Academy of Dermatology
- Obagi Medical Products Presents ELASTIderm Scientific Posters at the 65th Annual Meeting of the American Academy of Dermatology
- Power3 Medical Products Files Utility Patent Application on Discovery That Distinguishes Between Parkinson's and ALS; New Power3 Study Reveals Serum Biomarkers for Early ID of Parkinson's and ALS
- Utah Medical Products, Inc. Announces Filing a Request for Reconsideration With HHS
- Power3 Medical Products Offers Presentations at Major Scientific Conferences
- Power3 Medical Products Updates IP Position
 |
 |
User Comments (0)
RSS Feeds